Biotech ETFs Pop Amid Pending J&J Vaccine Approval
February 24, 2021 at 15:36 PM EST
Biotech ETFs are climbing Wednesday as the Food and Drug Administration’s staff endorsed Johnson & Johnson’s coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.S. marketplace. The staff report released Wednesday is a preliminary step designed to prepare...